Literature DB >> 21333317

The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.

Aron R Marquitz1, Anuja Mathur, Cyd Stacy Nam, Nancy Raab-Traub.   

Abstract

In Epstein-Barr Virus infected epithelial cancers, the alternatively spliced BamHI A rightward transcripts (BARTs) are abundantly expressed and are the template for two large clusters of miRNAs. This study indicates that both of these clusters independently can inhibit apoptosis in response to etoposide in an epithelial cell line. The Bcl-2 interacting mediator of cell death (Bim) was identified using gene expression microarrays and bioinformatic analysis indicated multiple potential binding sites for several BART miRNAs in the Bim 3'UTR. Bim protein was reduced by Cluster I and the individual expression of several miRNAs, while mRNA levels were unaffected. In reporter assays, the Bim 3' untranslated region (UTR) was inhibited by both clusters but not by any individual miRNAs. These results are consistent with the BART miRNAs downregulating Bim post-transcriptionally in part through the 3'UTR and suggest that there are miRNA recognition sites within other areas of the Bim mRNA.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333317      PMCID: PMC3340891          DOI: 10.1016/j.virol.2011.01.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.

Authors:  Zachary L Pratt; Malika Kuzembayeva; Srikumar Sengupta; Bill Sugden
Journal:  Virology       Date:  2009-02-12       Impact factor: 3.616

Review 2.  Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.

Authors:  Masashi Fukayama; Rumi Hino; Hiroshi Uozaki
Journal:  Cancer Sci       Date:  2008-07-04       Impact factor: 6.716

3.  Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.

Authors:  Jia Yun Zhu; Thorsten Pfuhl; Natalie Motsch; Stephanie Barth; John Nicholls; Friedrich Grässer; Gunter Meister
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

4.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

Authors:  Daphna Nachmani; Noam Stern-Ginossar; Ronit Sarid; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

5.  Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.

Authors:  Katherine Cosmopoulos; Michiel Pegtel; Jared Hawkins; Howell Moffett; Carl Novina; Jaap Middeldorp; David A Thorley-Lawson
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

6.  Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing.

Authors:  Rachel Hood Edwards; Aron R Marquitz; Nancy Raab-Traub
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

Review 7.  BH3-only proteins in apoptosis and beyond: an overview.

Authors:  E Lomonosova; G Chinnadurai
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

8.  Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells.

Authors:  Kazuya Terasawa; Atsuhiko Ichimura; Fumiaki Sato; Kazuharu Shimizu; Gozoh Tsujimoto
Journal:  FEBS J       Date:  2009-04-25       Impact factor: 5.542

9.  Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs.

Authors:  Joseph M Ziegelbauer; Christopher S Sullivan; Don Ganem
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

10.  Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.

Authors:  Kostas Paschos; Paul Smith; Emma Anderton; Jaap M Middeldorp; Robert E White; Martin J Allday
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

View more
  82 in total

1.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

2.  Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.

Authors:  Aron R Marquitz; Anuja Mathur; Kathy H Y Shair; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

Review 3.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  The Epstein-Barr virus microRNA BART11-5p targets the early B-cell transcription factor EBF1.

Authors:  Nathan Ross; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2013-08-19

Review 5.  Genome editing and the next generation of antiviral therapy.

Authors:  Daniel Stone; Nixon Niyonzima; Keith R Jerome
Journal:  Hum Genet       Date:  2016-06-08       Impact factor: 4.132

Review 6.  Viruses and microRNAs: RISCy interactions with serious consequences.

Authors:  Bryan R Cullen
Journal:  Genes Dev       Date:  2011-09-06       Impact factor: 11.361

Review 7.  MicroRNAs as mediators of viral evasion of the immune system.

Authors:  Bryan R Cullen
Journal:  Nat Immunol       Date:  2013-02-15       Impact factor: 25.606

Review 8.  Multiple functions are mediated by the miRNAs of Epstein-Barr virus.

Authors:  Malika Kuzembayeva; Mitchell Hayes; Bill Sugden
Journal:  Curr Opin Virol       Date:  2014-05-10       Impact factor: 7.090

Review 9.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

10.  Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE.

Authors:  Hoyun Choi; Hanna Lee; Sae Rom Kim; Yong Song Gho; Suk Kyeong Lee
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.